Franklin Huang

Dr. Franklin Huang is a physician-scientist and medical oncologist at the University of California San Francisco (UCSF), specializing in prostate cancer research. His work focuses on genetic differences between cancer cells and normal tissue, precision medicine, and global oncology. He leads the Huang Lab, which investigates prostate cancer disparities in African American populations and explores new drug targets. His research is supported by major organizations including the NIH, Prostate Cancer Foundation, and Chan Zuckerberg Biohub.

Education:

• AB in Biology, Harvard College (1999)
• MD, Washington University School of Medicine (2008)
• PhD in Genetics, Harvard University (2007)
• Residency in Internal Medicine at Massachusetts General Hospital (2008–2010)
• Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute (2010–2018)

Research Interests: His studies emphasize understanding cancer disparities, especially in African American and Hispanic/Latina populations. Key areas include:

• Genetic and epigenetic drivers of prostate cancer aggressiveness
• Targeted therapies for metastatic castration-resistant prostate cancer
• Global oncology initiatives to improve cancer care access in underserved regions

Grants & Awards:

• Chan Zuckerberg Biohub Investigator (2022)
• Prostate Cancer Foundation Young Investigator Award (2014)
• American Society of Clinical Oncology Young Investigator Award (2013)

Advocacy & Outreach: As co-founder of Global Oncology, he works to expand cancer treatment access globally. His team has conducted landmark studies on healthcare disparities in Belize and developed culturally tailored educational tools for genetic testing in prostate cancer.

Labs & Collaborations: His lab collaborates with institutions worldwide, including the Chan Zuckerberg Initiative and the Prostate Cancer Foundation. Ongoing projects include single-cell profiling of tumor heterogeneity and translational studies on immune checkpoint inhibitors.